Intestinal sulfate and phosphate transporters

Intestinal sulfate and phosphate transporters are specialized membrane proteins located primarily on the apical surface of enterocytes, where they facilitate the absorption of inorganic anions from the intestinal lumen into the bloodstream. The most prominent members include the sodium-dependent phosphate cotransporter 2b (NaPi-IIb, encoded by SLC34A2) and various sulfate transporters from the SLC26 family, such as the Down-Regulated in Adenoma (DRA, encoded by SLC26A3) protein (UniProt: O95436, P40879). These transporters are essential for maintaining systemic mineral balance; for instance, NaPi-IIb accounts for a significant portion of active intestinal phosphate absorption, which is often dysregulated in patients with chronic kidney disease (CKD) (PubMed: 21903961). In CKD, excessive phosphate absorption leads to hyperphosphatemia, a condition strongly associated with vascular calcification and increased mortality, making NaPi-IIb a high-priority therapeutic target (PubMed: 30355611). Similarly, sulfate transporters are vital for the synthesis of glycosaminoglycans and detoxification processes, and their dysfunction can lead to metabolic or gastrointestinal disorders like congenital chloride diarrhea (PubMed: 15194704). Current drug development focuses on small-molecule inhibitors of NaPi-IIb, such as DS-1001 and ASP3325, to provide a more targeted approach to managing phosphate levels compared to traditional non-specific phosphate binders (ClinicalTrials.gov: NCT03321448). Additionally, the NHE3 inhibitor Tenapanor indirectly reduces phosphate absorption by modulating the paracellular pathway and potentially affecting these transporters' environment. Targeting these proteins offers a mechanism to control mineral levels directly at the point of entry, potentially reducing the pill burden associated with current therapies.

Other names

SLC34A2SLC26A3NaPi-IIbDRASodium-dependent phosphate cotransporter 2BChloride/bicarbonate exchangerSLC20A1PiT-1SLC26A2DTDST

Inhibition of sodium-dependent phosphate cotransport or anion exchange across the intestinal apical membrane to reduce systemic absorption of inorganic anions.